Q1 Earnings Estimate for electroCore Issued By HC Wainwright

electroCore, Inc. (NASDAQ:ECOR) – Investment analysts at HC Wainwright lowered their Q1 2025 EPS estimates for electroCore in a research note issued on Thursday, March 13th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings per share of ($0.59) for the quarter, down from their prior forecast of ($0.26). HC Wainwright has a “Buy” rating and a $25.00 price target on the stock. The consensus estimate for electroCore’s current full-year earnings is ($1.49) per share. HC Wainwright also issued estimates for electroCore’s Q2 2025 earnings at ($0.45) EPS, Q3 2025 earnings at ($0.36) EPS, Q4 2025 earnings at ($0.29) EPS, FY2025 earnings at ($1.70) EPS, FY2026 earnings at $0.45 EPS and FY2027 earnings at $1.33 EPS.

Separately, LADENBURG THALM/SH SH lowered their target price on shares of electroCore from $28.00 to $26.00 and set a “buy” rating for the company in a research note on Thursday, March 13th.

electroCore Stock Down 3.5 %

Shares of NASDAQ ECOR opened at $8.26 on Monday. electroCore has a twelve month low of $5.32 and a twelve month high of $19.49. The firm has a fifty day simple moving average of $15.64 and a 200 day simple moving average of $12.37. The company has a market capitalization of $54.98 million, a PE ratio of -4.51 and a beta of 0.24.

Insider Buying and Selling at electroCore

In related news, Director Thomas J. Errico purchased 6,000 shares of the firm’s stock in a transaction on Monday, March 17th. The stock was purchased at an average cost of $8.10 per share, with a total value of $48,600.00. Following the completion of the purchase, the director now owns 256,401 shares in the company, valued at approximately $2,076,848.10. This trade represents a 2.40 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 19.70% of the company’s stock.

Institutional Investors Weigh In On electroCore

Several hedge funds and other institutional investors have recently bought and sold shares of ECOR. Jane Street Group LLC acquired a new position in shares of electroCore during the fourth quarter valued at about $278,000. Marshall Wace LLP acquired a new position in shares of electroCore during the fourth quarter valued at about $438,000. NewEdge Advisors LLC acquired a new position in shares of electroCore during the fourth quarter valued at about $274,000. Renaissance Technologies LLC grew its holdings in shares of electroCore by 80.6% during the fourth quarter. Renaissance Technologies LLC now owns 131,786 shares of the company’s stock valued at $2,136,000 after buying an additional 58,800 shares during the last quarter. Finally, DnB Asset Management AS acquired a new position in shares of electroCore during the fourth quarter valued at about $180,000. 26.74% of the stock is owned by institutional investors.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.